Immunoassay interference complicating management of Cushing's disease: the onus is on the clinician and the laboratory

Ann Clin Biochem. 2017 Jan;54(1):183-184. doi: 10.1177/0004563216657362. Epub 2016 Jul 20.

Authors

Kay W Choy¹, Jessie Teng², Nilika Wijeratne^{1

3

4}, Chin Y Tan², James Cg Doery^{1

3}

Affiliations

¹ 1 Department of Pathology, Monash Medical Centre, Victoria, Australia.
² 2 Department of Endocrinology, Monash Medical Centre, Victoria, Australia.
³ 3 Department of Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria, Australia.
⁴ 4 Dorevitch Pathology, Victoria, Australia.

PMID: 27303060
DOI: 10.1177/0004563216657362

No abstract available

Publication types

Case Reports

MeSH terms

Adrenocorticotropic Hormone / blood*
Clinical Competence
Disease Management
False Positive Reactions
Female
Follicle Stimulating Hormone / blood
Humans
Hydrocortisone / blood
Hypophysectomy*
Immunoassay / adverse effects*
Luteinizing Hormone / blood
Middle Aged
Pituitary ACTH Hypersecretion / blood
Pituitary ACTH Hypersecretion / diagnosis*
Pituitary ACTH Hypersecretion / pathology
Pituitary ACTH Hypersecretion / surgery
Pituitary Gland / metabolism
Pituitary Gland / pathology
Pituitary Gland / surgery

Substances

Adrenocorticotropic Hormone
Luteinizing Hormone
Follicle Stimulating Hormone
Hydrocortisone